CAS 2703745-70-2 FFAGLDD (MMP9-Selective Cleavage Peptide)

Send Inquiry
CAS 2703745-70-2 FFAGLDD (MMP9-Selective Cleavage Peptide)
Details
•Product Name: FFAGLDD (MMP9-Selective Cleavage Peptide)
•CAS No.: 2703745-70-2
•Synonyms: MMP9-Selective Cleavage Peptide
•Sequence: Phe-Phe-Ala-Gly-Leu-Asp-Asp (FFAGLDD)
•Number of Amino Acids: 7
•Molecular Formula: C₃₇H₄₉N₇O₁₂
•Molecular Weight: 783.82 Da
•Purity: HPLC ≥95%
Related Documents: COA/MS/HPLC Reports, Peptide Solubility and Storage Guide
Category
Drug Delivery Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2703745-70-2 ffagldd (mmp9-selective cleavage peptide) in China, also supports custom service. Welcome to wholesale bulk high quality cas 2703745-70-2 ffagldd (mmp9-selective cleavage peptide) from our factory. Contact us for more details.

 

  ↵

Description FFAGLDD (CAS: 2703745-70-2) is a 7-amino-acid peptide with the sequence Phe-Phe-Ala-Gly-Leu-Asp-Asp (FFAGLDD), a matrix metalloproteinase 9 (MMP9, also known as gelatinase B) selective cleavage peptide, used for cytosolic delivery of doxorubicin (DOX) to achieve spatiotemporally controlled slow drug delivery and release. MMP9 is a zinc-dependent endopeptidase that is highly expressed in the tumor microenvironment, inflammatory sites, and tissue remodeling processes, participating in extracellular matrix degradation, tumor invasion and metastasis, angiogenesis, and other pathological processes. The FFAGLDD sequence contains a specific motif recognized and cleaved by MMP9, which can be cleaved by MMP9 at a specific site, thereby achieving enzyme-responsive controlled drug release. Compared to product #8 (FFAGLDD TFA), this product is in the free base form (without TFA salt), suitable for experimental systems sensitive to TFA. Design features of FFAGLDD: (1) N-terminal diphenylalanine (Phe-Phe) - provides hydrophobicity, can bind to the hydrophobic pockets of the MMP9 active site, and is a key element for MMP9 recognition; (2) intermediate alanine-glycine-leucine (Ala-Gly-Leu) - constitutes the core sequence of the MMP9 cleavage site; (3) C-terminal diaspartic acid (Asp-Asp) - provides negative charge, regulates peptide solubility and electrostatic interactions with the MMP9 active site. Applications of FFAGLDD include: (1) tumor-targeted drug delivery - as an enzyme-responsive linker connecting chemotherapeutic drugs (such as doxorubicin DOX) to targeting ligands or nanocarriers, which are cleaved under conditions of high MMP9 expression in the tumor microenvironment, achieving spatiotemporally controlled drug release; (2) prodrug design - conjugating drugs with FFAGLDD to form prodrugs, where active drugs are only cleaved and released at tumor sites with high MMP9 expression; (3) MMP9 activity detection - constructing MMP9 activity fluorescent probes; (4) tumor imaging - after labeling with radionuclides or fluorescent dyes, used for imaging diagnosis of MMP9-high-expressing tumors; (5) hydrogel degradation regulation - introducing FFAGLDD into the hydrogel network to achieve MMP9-responsive degradation. The FFAGLDD free base form is suitable for biomedical applications requiring avoidance of TFA residues, such as in vivo injection experiments and cell culture experiments.

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
FFAGLDD FFAGLDD heptapeptide; di-aspartic acid free peptide Protease inhibitor, enzyme binding probe, protein interaction study, acidic polypeptide Linear heptapeptide Phe-Phe-Ala-Gly-Leu-Asp-Asp with diphenylalanine hydrophobic motif and di-aspartic acid anionic groups; serves as aspartic protease inhibitor lead and protein interaction probe C₃₅H₄₆N₆O₁₁ 730.32 ~730.8 Free peptide 7

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-FFA07 White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Free acidic peptide is soluble in alkaline buffers, dilute acetic acid and DMF. Limited water solubility of di-aspartic acid sequence at neutral pH; significantly improved solubility under alkaline conditions due to carboxyl dissociation. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-FFA07 FFAGLDD free acidic heptapeptide as protease inhibitor and protein interaction probe FFAGLDD free peptide is an acidic heptapeptide containing two aspartic acids. The diphenylalanine hydrophobic motif binds to the hydrophobic pocket of target enzymes, and the di-aspartic acid side chains form electrostatic interactions with the enzyme active site. It serves as a lead molecule for aspartic protease inhibitors and a probe for protein interaction studies. Protease inhibitor development, enzymology & mechanism research, neurodegenerative disease research, protein interaction, drug lead optimization Aspartic protease active site; enzyme substrate binding pocket; electrostatic & hydrophobic interactions

 

 

 

 

Hot Tags: cas 2703745-70-2 ffagldd (mmp9-selective cleavage peptide), China cas 2703745-70-2 ffagldd (mmp9-selective cleavage peptide) manufacturers, suppliers, factory, 651328-78-8, CAS 395069 92 8, CAS 997 20 6, drug delivery peptides, therapeutic and pharmaceutical peptides, Transportan

Send Inquiry